LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Search

Intuitive Surgical Inc

Fermé

SecteurSoins de santé

492.86 1.56

Résumé

Variation du prix de l'action

24h

Actuel

Min

478.79

Max

493.11

Chiffres clés

By Trading Economics

Revenu

90M

800M

Ventes

361M

2.9B

P/E

Moyenne du Secteur

62.874

61.417

Marge bénéficiaire

27.894

Employés

17,021

EBITDA

70M

1.1B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+31.2% upside

Dividendes

By Dow Jones

Prochains Résultats

21 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-17B

175B

Ouverture précédente

491.3

Clôture précédente

492.86

Sentiment de l'Actualité

By Acuity

28%

72%

55 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Intuitive Surgical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 oct. 2025, 23:55 UTC

Actions en Tendance

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 oct. 2025, 21:14 UTC

Résultats
Principaux Mouvements du Marché

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 oct. 2025, 20:38 UTC

Résultats

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 juil. 2025, 21:13 UTC

Résultats

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

17 févr. 2026, 14:48 UTC

Résultats

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

23 janv. 2026, 16:07 UTC

Résultats

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 janv. 2026, 12:58 UTC

Résultats

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 janv. 2026, 21:11 UTC

Résultats

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 janv. 2026, 21:11 UTC

Résultats

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 janv. 2026, 21:10 UTC

Résultats

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q Net $794.8M >ISRG

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 oct. 2025, 12:38 UTC

Résultats

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 oct. 2025, 12:01 UTC

Résultats

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 oct. 2025, 15:42 UTC

Résultats

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 oct. 2025, 12:34 UTC

Résultats

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 oct. 2025, 11:49 UTC

Résultats

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 oct. 2025, 20:08 UTC

Résultats

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 oct. 2025, 20:08 UTC

Résultats

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Net $704.4M >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 oct. 2025, 20:05 UTC

Résultats

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 juil. 2025, 20:14 UTC

Résultats

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 juil. 2025, 20:13 UTC

Résultats

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 juil. 2025, 20:13 UTC

Résultats

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

Comparaison

Variation de prix

Intuitive Surgical Inc prévision

Objectif de Prix

By TipRanks

31.2% hausse

Prévisions sur 12 Mois

Moyen 647.56 USD  31.2%

Haut 750 USD

Bas 550 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

14

Achat

5

Maintien

0

Vente

Score Technique

By Trading Central

514.59 / 539.05Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Weak Bullish Evidence

Long Terme

Strong Bullish Evidence

Sentiment

By Acuity

55 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat